Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Information for Cancer Researchers

The Abramson Cancer Center supports a dynamic research effort focused on cancer detection, diagnosis, treatment, and prevention. The following links may be of interest to Abramson Cancer Center investigators:

  • Search for active Penn trials
  • Clinical Trials Scientific Review and Monitoring Committee: This website contains information and resources for Penn investigators initiating clinical research projects related to cancer. All cancer clinical trials must be approved by the Clinical Trials Scientific Review and Monitoring Committee before activation.
  • Penn policy on submission of new cancer clinical protocols
  • Abramson Cancer Center's NCI-Approved Data Safety and Monitoring Plan
  • Abramson Cancer Center's Clinical Research Unit: The Clinical Research Unit (CRU) assists Abramson Cancer Center investigators in the development and conduct of clinical research. Directed by Dan Vogl, MD, the CRU collects, monitors, and analyzes data for intramural and cooperative group trials. The specific objective of the CRU is to provide the necessary infrastructure to support adult therapeutic clinical trial research in the ACC. The CRU provides a full spectrum of services including protocol development, budget and financial analysis, regulatory affairs expertise, research nursing, and data management. As a centralized administrative unit, the CRU provides highly skilled research personnel to support the ACC clinical researchers who would not otherwise have the resources necessary to properly conduct clinical trials. For more information, contact
  • Perelman School of Medicine Office of Clinical Research
  • Perelman School of Medicine Patient Oriented Research Certification Program: Completion of this certification program is required of all Perelman School of Medicine Faculty, Clinical Care Associate Physicians and Physicians at affiliated hospitals who conduct patient-oriented research (clinical trials).
  • University of Pennsylvania Institutional Review Board (IRB): The University of Pennsylvania requires that all research projects involving humans as subjects or human material by reviewed and approved by the University of Pennsylvania IRB prior to initiation of any research-related activities, including recruitment and screening.
  • Tissue Banking: Tissue banking allows researchers to utilize resources and facilitate the discovery of information critical to improving cancer care. For information on the ACC's tissue banking services, contact Michael Feldman, MD, PhD at
  • Bioinformatics: The ACC collaborates with the Institute for Biomedical Informatics (IBI) Bioinformatics Core (BC) to meet the growing need for bioinformatics support among ACC members in the areas of massively parallel sequencing data analysis, bioinformatics application development, and multi-omics data management and integration. To provide this service, the ACC supports IBI's Taehyong Kim, PhD ( to assist in data analysis for pilot projects or analysis of preliminary data for a grant application. Dr. Kim can also assist investigators in the analysis of discrete data sets for manuscript publication. This service will provide support for multiple individuals, and thus Dr. Kim can only take on one project per investigator. Dr. Kim is pleased to consult on an individual basis to scope project need and support. Downstream statistical analyses of informatics data will continue to be provided by the ACC Biostatistics Core, which is committed to working closely with the IBI BC. Investigators interested in larger-scale bioinformatics support should contact the Director of the IBI BC, Paul Wang, PhD at
  • Search the ACC Events Bulletin Archive